Hanover - Delayed Quote EUR
Valneva SE (AYJ.HA)
2.9200
+0.0280
+(0.97%)
At close: May 2 at 5:25:31 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-67,218
-67,218
-202,744
-245,343
76,901
Investing Cash Flow
76,916
76,916
-20,585
-29,054
-93,117
Financing Cash Flow
30,682
30,682
63,081
215,116
154,504
End Cash Position
168,271
168,271
126,080
286,532
346,642
Capital Expenditure
-16,444
-16,444
-14,312
-29,322
-93,171
Issuance of Capital Stock
--
--
--
189,837
166,823
Issuance of Debt
--
--
81,111
39,331
859
Repayment of Debt
-6,487
-6,487
-5,224
-4,841
-4,761
Repurchase of Capital Stock
--
--
-240
--
--
Free Cash Flow
-83,662
-83,662
-217,056
-274,665
-16,270
12/31/2021 - 12/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.4320
+7.46%
328.SG MeiraGTx Holdings PLC
6.45
+4.03%
HTD.MU Corcept Therapeutics Inc
63.62
0.00%
25I.SG ImmuPharma PLC
0.0325
-1.52%
HQ1.MU Oruka Therapeutics Inc. R
9.10
0.00%
CLDWW Calidi Biotherapeutics, Inc.
0.0055
-15.38%
PI3.DU Gubra AS
54.00
+9.27%
22UA.MU BioNTech SE
91.15
-0.16%
GNFTF Genfit S.A.
3.5400
0.00%
BNTX.VI BioNTech SE
92.25
+1.26%